|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,594.00 GBX | -0.27% |
|
-1.87% | -8.67% |
EPS & Dividend: AstraZeneca PLC
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 2.87 | 2.9 | 2.9 | 3.1 | 3.2 | 3.341 | 3.522 | 3.657 |
| Rate of return | 2.44% | 2.15% | 2.15% | 2.37% | 1.72% | 1.97% | 2.08% | 2.16% |
| EPS 2 | 0.08 | 2.11 | 3.81 | 4.5 | 6.54 | 8.007 | 9.124 | 10.55 |
| Distribution rate | 3,588% | 137% | 76.1% | 68.9% | 48.9% | 41.7% | 38.6% | 34.7% |
| Reference price 2 | 117.51 | 135.16 | 135.02 | 131.05 | 185.60 | 169.43 | 169.43 | 169.43 |
| Nbr of stocks (in thousands) | 15,49,159 | 15,49,528 | 15,49,926 | 15,50,317 | 15,50,726 | 15,51,024 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 06/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
Past dividends: AstraZeneca PLC
| 19/02/2026 | Ex-dividend date - 1.595 GBX | 10:30 am |
| 07/08/2025 | Ex-dividend date - 0.767 GBX | 09:30 am |
Upcoming Events: AstraZeneca PLC
| 27/07/2026 | Earnings release | Q2 2026 | 11:30 am |
| 27/07/2026 | Earnings presentation | 04:15 pm |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 1.97% | 2.08% | 21.16x | 4.96x | 4.46x | |
| 0.57% | 0.64% | 35.04x | 21.39x | 12.53x | |
| 2.12% | 2.22% | 27.19x | 6.81x | 6.2x | |
| 2.7% | 2.84% | 33.15x | 12667.5x | 7.52x | |
| 3% | 3.07% | 17.85x | 6.61x | 4.43x | |
| 2.84% | 2.93% | 21.66x | 6.24x | 5.55x | |
| 3.44% | 3.35% | 14.45x | 6.38x | 5.41x | |
| 2.75% | 2.91% | 24.02x | 18.48x | 6.35x | |
| 2.42% | 2.5% | -48.37x | 8.47x | 5.78x | |
| 6.89% | 6.96% | 12.72x | 1.62x | 3.11x | |
| Average | 2.87% | 2.95% | 15.89x | 1,274.85x | 6.13x | |
| Weighted average by Cap. | 2.19% | 2.27% | 23.58x | 1,542.38x | 7.64x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition